SCHEMBL18156766

SCHEMBL18156766

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)C3(c5ccccc5-4)c4ccccc4-c4cc5oc6ccccc6c5cc43)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.39
KMT2A Q03164 8/20 0.38
MAPT P10636 7/20 0.38
MEN1 O00255 6/20 0.38
ALDH1A1 P00352 5/20 0.38
HPGD P15428 5/20 0.38
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 2/20 0.35
ATM Q13315 1/20 0.35
GLA P06280 1/20 0.35
MAPK1 P28482 1/20 0.34
PDK2 Q15119 1/20 0.34
TSHR P16473 2/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
PGR P06401 1/20 0.33
ALOX5 P09917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20224267 0.99 AHR (0.38) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL20224415 0.98 AHR (0.38) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL24039489 0.96 MAPT (0.37) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL21887634 0.96 AHR (0.38) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL18156774 0.96 AHR (0.38) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL20224354 0.95 AHR (0.38) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL20224416 0.94 PDK2 (0.36) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL20224360 0.94 AHR (0.37) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL20371309 0.94 AHR (0.38) AHRKMT2AMAPTMEN1ALDH1A1
SCHEMBL21158769 0.94 AHR (0.37) AHRKMT2AMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-11545634-B2 Heterocyclic spiro compounds MERCK PATENT GMBH (DE) 2023-01-03 US disclosed
EP-3708634-A1 HETEROCYCLIC SPIRO COMPOUNDS Merck Patent GmbH (DE) 2020-09-16 EP disclosed
US-10777750-B2 Heterocyclic spiro compounds BASF SE (DE) 2020-09-15 US disclosed
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-08-20 US disclosed
EP-3083880-B1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-04-01 EP disclosed
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20160308140-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME Research & Business Foundation Sungkyunkwan University (KR) 2016-10-20 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308140-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME Research & Business Foundation Sungkyunkwan University (KR) 2016-10-20 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE OR51E2, OCIAD1, OXA1L AHR 3239/4885KMT2A 2127/4885MAPT 2225/4885
US-20160308140-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME CCNE2, CRY1, CCNL2 AHR 3586/4885KMT2A 2569/4885MAPT 2963/4885
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 AHR 1148/4885KMT2A 3328/4885MAPT 3089/4885
US-11545634-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 AHR 1148/4885KMT2A 3328/4885MAPT 3089/4885
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 AHR 1148/4885KMT2A 3328/4885MAPT 3089/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 AHR 1148/4885KMT2A 3328/4885MAPT 3089/4885
US-10777750-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 AHR 1148/4885KMT2A 3328/4885MAPT 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.